Evidence map›Paper›PMID 33054766›Full record

ArticleJournal of neuroinflammation2020

The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response.

Shinrye Lee, Seyeon Kim, Ha-Young Kang, Hye Ryeong Lim, Younghwi Kwon, Myungjin Jo, Yu-Mi Jeon, Sang Ryong Kim, Kiyoung Kim, Chang Man Ha and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Loss of TDP-43 Drives Innate Immune Activation Through Relish inInternational journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. A pathologic study of Perivascular pTDP-43 Lin bodies in LATE-NC.Acta neuropathologica communications · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Shinrye LeeDementia Research Group, Korea Brain Research Institute (KBRI), Daegu, 41062, South Korea.
Seyeon KimDementia Research Group, Korea Brain Research Institute (KBRI), Daegu, 41062, South Korea.
Ha-Young KangGwangju Center, Korea Basic Science Institute (KBSI), Gwangju, 61886, South Korea.
Hye Ryeong LimResearch Division and Brain Research Core Facilities, Korea Brain Research Institute (KBRI), Daegu, 41062, South Korea.
Younghwi KwonDementia Research Group, Korea Brain Research Institute (KBRI), Daegu, 41062, South Korea.
Myungjin JoDementia Research Group, Korea Brain Research Institute (KBRI), Daegu, 41062, South Korea.
Yu-Mi JeonDementia Research Group, Korea Brain Research Institute (KBRI), Daegu, 41062, South Korea.
Sang Ryong KimSchool of Life Sciences, BK21 Plus KNU Creative BioResearch Group, Institute of Life Science & Biotechnology, Kyungpook National University, Daegu, 41566, South Korea.
Kiyoung KimDepartment of Medical Biotechnology, Soonchunhyang University, Asan, 31538, South Korea.
Chang Man HaResearch Division and Brain Research Core Facilities, Korea Brain Research Institute (KBRI), Daegu, 41062, South Korea.
Seongsoo LeeGwangju Center, Korea Basic Science Institute (KBSI), Gwangju, 61886, South Korea. soolee@kbsi.re.kr.
Hyung-Jun KimDementia Research Group, Korea Brain Research Institute (KBRI), Daegu, 41062, South Korea. kijang1@kbri.re.kr.
Korea Brain Research Institute · KRKorea Basic Science Institute · KRDaegu Gyeongbuk Institute of Science and Technology · KRKyungpook National University · KRSoonchunhyang University · KR

Funding

Korea Health Industry Development Institute HI14C1135Korea Health Industry Development Institute HI18C1241Ministry of Science, ICT and Future Planning 20-BR-02-08National Research Foundation of Korea NRF-2019R1F1A1045639National Research Foundation of Korea NRF-2020R1A2C4002366National Research Foundation of Korea NRF-2020R1F1A1058459Soonchunhyang University Kiyoung Kim
6 · The paper itself

Abstract

backgroundCytoplasmic inclusions of transactive response DNA binding protein of 43 kDa (TDP-43) in neurons and astrocytes are a feature of some neurodegenerative diseases, such as frontotemporal lobar degeneration with TDP-43 (FTLD-TDP) and amyotrophic lateral sclerosis (ALS). However, the role of TDP-43 in astrocyte pathology remains largely unknown.

methodsTo investigate whether TDP-43 overexpression in primary astrocytes could induce inflammation, we transfected primary astrocytes with plasmids encoding Gfp or TDP-43-Gfp. The inflammatory response and upregulation of PTP1B in transfected cells were examined using quantitative RT-PCR and immunoblot analysis. Neurotoxicity was analysed in a transwell coculture system of primary cortical neurons with astrocytes and cultured neurons treated with astrocyte-conditioned medium (ACM). We also examined the lifespan, performed climbing assays and analysed immunohistochemical data in pan-glial TDP-43-expressing flies in the presence or absence of a Ptp61f RNAi transgene.

resultsPTP1B inhibition suppressed TDP-43-induced secretion of inflammatory cytokines (interleukin 1 beta (IL-1β), interleukin 6 (IL-6) and tumour necrosis factor alpha (TNF-α)) in primary astrocytes. Using a neuron-astrocyte coculture system and astrocyte-conditioned media treatment, we demonstrated that PTP1B inhibition attenuated neuronal death and mitochondrial dysfunction caused by overexpression of TDP-43 in astrocytes. In addition, neuromuscular junction (NMJ) defects, a shortened lifespan, inflammation and climbing defects caused by pan-glial overexpression of TDP-43 were significantly rescued by downregulation of ptp61f (the Drosophila homologue of PTP1B) in flies.

conclusionsThese results indicate that PTP1B inhibition mitigates the neuronal toxicity caused by TDP-43-induced inflammation in mammalian astrocytes and Drosophila glial cells.

Indexed as

AnimalsAnimals, Genetically ModifiedAstrocytesCells, CulturedDNA-Binding ProteinsDrosophilaGene ExpressionInflammation MediatorsMaleMiceMice, Inbred C57BLNerve DegenerationProtein Tyrosine Phosphatase, Non-Receptor Type 1DNA-Binding ProteinsInflammation MediatorsProtein Tyrosine Phosphatase, Non-Receptor Type 1Ptpn1 protein, mouseTardbp protein, mouseAstrocytesNeurodegenerative diseaseNeuroinflammationProtein tyrosine phosphatase 1BTar DNA-binding protein 43

Identifiers

PMID33054766
PMCPMC7556969
OpenAlexW3093313402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.